%7B%22_type%22:%22chart%22,%22title%22:%22Pharmaceutical%20Industry%20Annual%20Net%20Income%20(2009-2023)%22,%22data%22:%5B%7B%22name%22:%22Net%20Income%22,%22theme%22:%22green%22,%22_key%22:%22961754f434b1%22,%22type%22:%22bar%22,%22dataset%22:%7B%22rows%22:%5B%7B%22cells%22:%5B%22'09%22,%2299831000000%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%221b018281-e11c-4ec6-a8ea-9ccb12df0517%22%7D,%7B%22cells%22:%5B%22'10%22,%2276781000000%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%22167929fd-9763-411c-90ff-5c080cfc3b95%22%7D,%7B%22_key%22:%2238da8d8b-faee-4cea-9313-4ee7d2761f99%22,%22cells%22:%5B%22'11%22,%2286467000000%5Cr%22%5D,%22_type%22:%22tableRow%22%7D,%7B%22cells%22:%5B%22'12%22,%2286235000000%5Cr%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%22ad8de669-82a5-49e0-b48d-f6cb9766a77d%22%7D,%7B%22cells%22:%5B%22'13%22,%2288820000000%5Cr%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%229a3c77e9-c4aa-4ff1-b3fd-3edc72436ed3%22%7D,%7B%22cells%22:%5B%22'14%22,%2277865000000%5Cr%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%221e57c705-b38e-41d1-9dd2-b2ce10faaf5c%22%7D,%7B%22cells%22:%5B%22'15%22,%2288603000000%5Cr%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%220940d374-1f88-4e35-80cd-19f0b0ad63dd%22%7D,%7B%22cells%22:%5B%22'16%22,%2271451000000%5Cr%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%221410ac15-dd63-4b33-9c94-5927a96575ed%22%7D,%7B%22_key%22:%2262e9fd7d-1253-4edb-9881-48e7eb54e8a6%22,%22cells%22:%5B%22'17%22,%2260085000000%5Cr%22%5D,%22_type%22:%22tableRow%22%7D,%7B%22cells%22:%5B%22'18%22,%2288424000000%5Cr%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%2219abe77d-69be-4200-9a4c-d20ea652a196%22%7D,%7B%22cells%22:%5B%22'19%22,%22101185000000%5Cr%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%2243b1f791-21f7-400e-bd2b-e9f59276acc8%22%7D,%7B%22cells%22:%5B%22'20%22,%2280948000000%5Cr%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%226590d391-f646-4f00-8a26-dad050c49b6d%22%7D,%7B%22cells%22:%5B%22'21%22,%22134334000000%5Cr%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%2216864f73-adaf-4f29-937b-5d5499dc549a%22%7D,%7B%22cells%22:%5B%22'22%22,%22146461000000%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%220abbfb6d-6912-4539-9720-f89da27dd184%22%7D,%7B%22cells%22:%5B%22'23%22,%22104546000000%22%5D,%22_type%22:%22tableRow%22,%22_key%22:%22db9ac097-a6a2-479c-883e-8ead8da73afb%22%7D%5D%7D,%22valueType%22:%22currency%22,%22_type%22:%22datasets%22%7D%5D,%22isLogarithmic%22:false,%22slug%22:%7B%22current%22:%22pharmaceutical-profits-industry%22,%22_type%22:%22slug%22%7D,%22axisName%22:%22Year%22,%22isStacked%22:false,%22isDouble%22:false,%22summary%22:%22The%20graph%20presents%20the%20annual%20net%20income%20of%20the%20pharmaceutical%20industry%20in%20the%20United%20States%20from%202009%20('09)%20to%202023%20('23).%20The%20x-axis%20represents%20the%20years,%20labeled%20from%20'09%20to%20'23,%20while%20the%20y-axis%20measures%20net%20income%20in%20billions%20of%20U.S.%20dollars.%20Throughout%20this%20period,%20net%20income%20varied%20significantly,%20ranging%20from%20a%20low%20of%20$60.085%20billion%20in%202017%20('17)%20to%20a%20high%20of%20$146.461%20billion%20in%202022%20('22).%20Notable%20peaks%20occurred%20in%202019%20('19)%20with%20$101.185%20billion,%202021%20('21)%20with%20$134.334%20billion,%20and%202023%20('23)%20with%20$104.546%20billion.%20The%20data%20reveals%20an%20overall%20upward%20trend%20in%20the%20pharmaceutical%20industry's%20net%20income,%20despite%20some%20fluctuations%20and%20declines%20in%20certain%20years.%20The%20information%20is%20displayed%20in%20a%20line%20graph%20format,%20emphasizing%20the%20growth%20and%20variability%20of%20annual%20net%20income%20within%20the%20industry%20over%20the%20fifteen-year%20span.%22,%22isVertical%22:false%7D
Limited by the top 15 companies: Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Sanofi, Novartis, Abbott Laboratories, Amgen, Bristol-Myers Squibb, Eli Lilly, AstraZeneca, Biogen, Viatris, Takeda Pharmaceutical
Source: macrotrends.net